Tibotec Pharmaceuticals, Ireland

Pharma

Dublin, Ireland, Ireland · Est. 2001

Tibotec Pharmaceuticals is a Johnson & Johnson subsidiary focused on developing antiviral medications for infectious diseases.

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Founded2001

HQDublin, Ireland, Ireland

Therapeutic Focus

AntiviralsHIVHepatitis C

Patent Expirations

1 patent group across drugs · Source: FDA Orange Book

DrugExpires

Regulatory

20071 event

FDAMar 5

Tekturna — TEKTURNA

Application NDA021985 (NDA)

20171 event

FDANov 14

Tekturna — TEKTURNA

Application NDA210709 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)